Ngā hua rapu - Michael Thiim
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial mā Robert J. Fontana, Jonathan Israel, Paula LeClair, Barbara F. Banner, Kristina Tortorelli, Norman D. Grace, Robert A. Levine, Gale S. Fiarman, Michael Thiim, Anthony S. Tavill, Herbert L. Bonkovsky
I whakaputaina 2000Artigo -
2
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents mā Meghan E. Sise, Allyson K. Bloom, Jessica Wisocky, Ming Lin, Jenna Gustafson, Andrew L. Lundquist, David Steele, Michael Thiim, Winfred W. Williams, Nikroo Hashemi, Arthur Y. Kim, Ravi Thadhani, Raymond T. Chung
I whakaputaina 2015Artigo -
3
Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease mā Nneka N. Ufere, John Donlan, Lauren Waldman, Jules L. Dienstag, Lawrence S. Friedman, Kathleen E. Corey, Nikroo Hashemi, Peter J. Carolan, Alan C. Mullen, Michael Thiim, Irun Bhan, Ryan David Nipp, Joseph A. Greer, Jennifer S. Temel, Raymond T. Chung, Areej El‐Jawahri
I whakaputaina 2019Artigo -
4
Physicians’ Perspectives on Palliative Care for Patients With End‐Stage Liver Disease: A National Survey Study mā Nneka N. Ufere, John Donlan, Lauren Waldman, Arpan Patel, Jules L. Dienstag, Lawrence S. Friedman, Kathleen E. Corey, Nikroo Hashemi, Peter J. Carolan, Alan C. Mullen, Michael Thiim, Irun Bhan, Ryan David Nipp, Joseph A. Greer, Jennifer S. Temel, Raymond T. Chung, Areej El‐Jawahri
I whakaputaina 2019Artigo -
5
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning mā Emily D. Bethea, Ashwini Arvind, Jenna Gustafson, Karin L. Andersson, Daniel S. Pratt, Irun Bhan, Michael Thiim, Kathleen E. Corey, Patricia P. Bloom, J.F. Markmann, Heidi Yeh, Nahel Elias, Shoko Kimura, Leigh Anne Dageforde, Alex G. Cuenca, Tatsuo Kawai, Kassem Safa, Winfred W. Williams, Hannah Gilligan, Meghan E. Sise, Jay A. Fishman, Camille N. Kotton, Arthur Kim, Christin C. Rogers, Sarah Shao, Mariesa Cote, Linda Irwin, Paul Myoung, Raymond T. Chung
I whakaputaina 2019Artigo -
6
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies mā Surendra Pal Chaudhary, Stephanie Reyes, Matthew Chase, Aparna Govindan, Lei Zhao, Jay Luther, Irun Bhan, Emily D. Bethea, Joseph W. Franses, Elizabeth Paige Walsh, Leigh Anne Dageford, Shoko Kimura, Nahel Elias, Heidi Yeh, James Markman, Adel Bozorgzadeh, Kenneth Tanabe, Cristina R. Ferrone, Andrew X. Zhu, Karin L. Andersson, Michael Thiim, Onofrio A. Catalano, Avinash Kambadakone, Parsia A. Vagefi, Motaz Qadan, Daniel S. Pratt, Nikroo Hashemi, Kathleen E. Corey, Joseph Misdraji, Lipika Goyal, Jeffrey W. Clark
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Disease
Gastroenterology
Immunology
Virus
Hepatitis C
Hepatitis C virus
Intensive care medicine
Nursing
Palliative care
Transplantation
Advance care planning
Adverse effect
Alanine transaminase
Alpha interferon
Antiviral therapy
Antiviral treatment
Biology
Biopsy
Chronic hepatitis
Cohort
Cryoglobulin
Cryoglobulinemia
End-of-life care
Etiology
Family medicine
Fatty liver
Group A
Group B